Cullinan Oncology LLC
Biotechnology
Healthcare
CGEM
58.34 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
7.30
52 week high
23.25
high
8.10
52 week low
7.25
low
6.93
growth
-66.85 %
previous Close
7.32
P/E ratio
market cap
709 M
div yield
0
usd
Sep 2024
qoq
revenue
0.00 %
net incoming
-40.56 M
3.49 %
eps
0.00 %
8.00 %
eps surprise
14.81 %
net profit margin
-4056000000.00 %
0.00 %
operating incoming
-48.86 M
2.34 %
net change in cash
-12.94 M
-131.71 %
cash on hand
102 M
-11.25 %
cost of revenue
0.00 %
top top